Super pumped that our paper is now online at nature.com/articles/s4146… Huge congrats to Gloria Asantewaa, Ph.D. and Emily Tuttle for leading this paper across the finish line! Big thanks to the Editorial staff at Nature Communications and reviewers for improving the paper.

Cohort study including 660k+ women with unilateral breast cancer and followed up for 20 years found that bilateral mastectomy was associated with a statistically significant reduction of contralateral breast cancer risk but not breast cancer mortality. ja.ma/46BmJJT

"Scientists need more time to think" ➡️This perspective speaks to me! 💯 -Administrative bloat, email overuse, meetings for meetings...pull time away. Finding time to think is very hard...but essential. 🤔 nature.com/articles/d4158…

Congratulations to Arya Roy - joining our The James Breast Med Onc Team - and collaborator/friend Asrar AlAhmadi, MD, MAS-CR (أسرار)! Way to go!

“Pelotonia is a movement. Pelotonia Is a symbol of hope. — Margaret Gatti-Mays, MD, MPH #EndingCancer

What a great day - inspired by the incredible community outpouring of support for Pelotonia The James Great 50 miles w Margaret Gatti-Mays MD MPH FACP Darren Mays Dionisia Quiroga, DO, PhD Phil Hart…& 7000 strong out riding this weekend! Ohio State Medical Oncology The Ohio State University Wexner Medical Center The Ohio State University College of Medicine

The truth about LIQUID BIOPSIES: only ⁦Christian Rolfo⁩ can clarify all the myths and facts about where we are and where we are heading on #HealthcareUnfiltered A must listen and watch - here’s a clip and the link - please share & subscribe. podcasts.apple.com/us/podcast/hea…

#ICYMI .Eric Miller The James leads Alliance for Clinical Trials in Oncology A022101/ERASur, a trial for patients w/metastatic #colorectalcancer that compares total ablative therapy & usual systemic therapy to usual systemic therapy alone: bit.ly/Alliance-A0221… #NCI #NCTN .Fight Colorectal Cancer .Colorectal Cancer Alliance

👩🏽‍🏫 my ASCO TECAG colleagues and I put together this workbook on the what, when, why, and how of mentoring for #hemeonc trainees and early career physicians Check it out 👀 and let us know how you’ve been able to form effective mentoring relationships! ASCO Hem-Onc Fellows Network

We need more studies breaking out ILC vs. IDC in National Cancer Institute & industry trials! Congrats to Julia Foldi, MD PhD Adrian Lee Dr. Steffi Oesterreich NRG Oncology team

Radiation therapy followed by intrathecal trastuzumab and pertuzumab for HER2+ breast leptomeningeal disease is safe with initial intracranial control results that appear encouraging. ja.ma/4fAaPDY Kamran Ahmed Moffitt Cancer Center

Took my sons to play ball & 1 asked about the #3132 sport court - told him about my amazing HS classmate Edward (Ned) Smith, an incredible all around person, his journey w cancer, & Pickles Group. Thanks to #3132 effort to honor Ned & give me a chance to share him w my boys! Upper Arlington Lacrosse Association

A beautifully crafted review “Towards targeting the breast cancer immune microenvironment” in Nature Reviews Cancer by Sherene Loi, MD et al not only closes a gap in our up to date understanding of immune microenvironment, but is graphically 🔝 Bravo. Required read. nature.com/articles/s4156…

👋Welcome Arya Roy to the The James Medical Oncology team! We are excited to work with you!

Phase I/Ib trial-Inavolisib + Palbociclib + ET for PIK3CAm HR+ HER2- MBC now published .OncoAlert Memorial Sloan Kettering Cancer Center MSK Department of Medicine Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC… #bcsm